RESERVOIR 44111 VENTRICULAR BURR HOLE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,other report with the FDA on 2018-04-24 for RESERVOIR 44111 VENTRICULAR BURR HOLE manufactured by Medtronic Neurosurgery.

Event Text Entries

[106736990] Concomitant prods and therapy dates: brineura (cerliponase alfa) solution for infusion; dose: unknown, icv; therapy date: (b)(6) 2017 to unknown. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[106737311] On an unspecified date, an ommaya 12 mm reservoir, model # 44111 was implanted. On an unspecified date in (b)(6) 2017, the patient initiated treatment with brineura (dose and frequency were not reported, icv) for the indication of neuronal ceroid lipofuscinosis. The most recent dose was administered on an unspecified date. On an unspecified date, the patient came in for an infusion. It was noted that the ommaya site looked edematous and was highly suspicious of a device leakage. A cerebrospinal fluid (csf) culture showed red blood cell (rbc) 11, white blood cell (wbc) 131, and protein 139. 2 mg/dl (units and reference range not reported). Culture showed no growth after one day. No treatment for the event was reported. The action taken with brineura due to the event was not reported. The outcome of the event was not reported. The event was assessed as related to the patient's ommaya reservoir device.
Patient Sequence No: 1, Text Type: D, B5


[108351825] Concomitant prods and therapy dates: brineura (cerliponase alfa) solution for infusion; dose 300mg, qow, icv; therapy date: (b)(6) 2017 to unknown date. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[108351826] Additional information received reported that on (b)(6) 2017, the patient initiated treatment with brineura (300 mg, qow). On (b)(6) 2018, at the clinic, the patient's ommaya reservoir site was noted to be soft with swelling and fluid around the area. No redness or external leakage was noted. His vital signs were within normal limits and his behavior was normal and at baseline. A neurosurgeon was consulted and the diagnosis was early pseudomeningocele around the reservoir; perhaps hydrocephalus of the communicating type or related to infusion. No action taken was with brineura due to the event. The outcome of the event was reported as recovering/resolved.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2021898-2018-00221
MDR Report Key7454793
Report SourceHEALTH PROFESSIONAL,OTHER
Date Received2018-04-24
Date of Report2018-05-15
Date of Event2018-04-10
Date Mfgr Received2018-05-14
Date Added to Maude2018-04-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTACY RUEMPING
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635260594
Manufacturer G1MEDTRONIC NEUROSURGERY
Manufacturer Street125 CREMONA DRIVE
Manufacturer CityGOLETA CA 93117
Manufacturer CountryUS
Manufacturer Postal Code93117
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRESERVOIR 44111 VENTRICULAR BURR HOLE
Generic NamePORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVENTRICULAR
Product CodeLKG
Date Received2018-04-24
Model Number44111
Catalog Number44111
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROSURGERY
Manufacturer Address125 CREMONA DRIVE GOLETA CA 93117 US 93117


Patients

Patient NumberTreatmentOutcomeDate
10 2018-04-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.